SCHEMBL24176646

SCHEMBL24176646

CC(C)(C)OC(=O)N(C(=O)OC(C)(C)C)c1ncc(-c2ccc(F)c(N)c2)n1C(=O)OC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 4/20 0.35
HDAC1 Q13547 3/20 0.35
NR1H2 P55055 7/20 0.34
BACE1 P56817 2/20 0.34
RIPK1 Q13546 1/20 0.33
BACE2 Q9Y5Z0 1/20 0.33
NR1H3 Q13133 2/20 0.32
GPR119 Q8TDV5 1/20 0.32
TTK P33981 1/20 0.32
AAK1 Q2M2I8 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32
NPC1 O15118 1/20 0.32
TP53 P04637 1/20 0.32
PKM P14618 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24176882 0.87 CFTR (0.38) NR1H2BACE1TTK
SCHEMBL24176651 0.85 NR1H2 (0.38) NR1H2NR1H3GPR119TTKAAK1
SCHEMBL24176648 0.83 FYN (0.39) NR1H2NR1H3TTK
SCHEMBL13655241 0.77 SMN1; SMN2 (0.36) NR1H2NPC1TP53RAB9ASMN1; SMN2
SCHEMBL13655217 0.75 NR1H2 (0.35) NR1H2NR1H3GPR119TTKAAK1
SCHEMBL10117875 0.74 NPC1 (0.35) NR1H2NR1H3GPR119TTKAAK1
SCHEMBL13663132 0.73 PTPN1 (0.53) NPC1RAB9A
SCHEMBL30277630 0.73 CYP1A1 (0.35) HDAC1BACE1BACE2AAK1GABRG2
SCHEMBL10117698 0.72 IDO1 (0.41) NR1H2NR1H3GPR119AAK1NPC1
SCHEMBL13655220 0.71 HDAC8 (0.43) HDAC2HDAC1NR1H2AAK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11582970-B2 2-aminoimidazole-phenyl derivatives useful for controlling microbial growth NORTH CAROLINA STATE UNIVERSITY (US) 2023-02-21 US disclosed
US-20220000118-A1 2-AMINOIMIDAZOLE-PHENYL DERIVATIVES USEFUL FOR CONTROLLING MICROBIAL GROWTH NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2022-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11582970-B2 2-aminoimidazole-phenyl derivatives useful for controlling microbial growth DDC, IL4I1, ING2 HDAC2 213/4885HDAC1 685/4885NR1H2 4595/4885
US-20220000118-A1 2-AMINOIMIDAZOLE-PHENYL DERIVATIVES USEFUL FOR CONTROLLING MICROBIAL GROWTH DDC, IL4I1, ING2 HDAC2 213/4885HDAC1 685/4885NR1H2 4595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.